American Society of Hematology

SHERPA: Blue

People

  1. Giralt
    Giralt
  2. Zelenetz
    Zelenetz
  3. Levine
    Levine
  4. Tallman
    Tallman
  5. Perales
    Perales
  6. O'Reilly
    O'Reilly
  7. Horwitz
    Horwitz
  8. Devlin
    Devlin
  9. Kernan
    Kernan
  10. Abdel-Wahab
    Abdel-Wahab

Groups

  1. Department of Medicine (3847)
  2. Hematologic Malignancies, Division of (3642)
  3. Center for Hematologic Malignancies (3544)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1290)
  6. Sloan Kettering Institute Faculty (1065)
  7. Bone Marrow Transplant (936)
  8. Center for Molecular Imaging and Biotechnology (CMIB) (931)
  9. Lymphoma (899)
  10. Tow Center for Developmental Oncology (TCDO) (863)
Search Within
Formats
  1. Meeting Abstract (4152)
  2. Journal Article (1242)
  3. Research Letter (44)
  4. Review (44)
  5. Editorial (34)
  6. Guidelines (13)
  7. Correspondence (7)
  8. Miscellaneous (3)
Groups
  1. Department of Medicine (3847)
  2. Hematologic Malignancies, Division of (3642)
  3. Center for Hematologic Malignancies (3544)
  4. GSK Faculty (1553)
  5. Adult Leukemia (1290)
  6. Sloan Kettering Institute Faculty (1065)

More Groups

People
  1. Sergio Giralt (337)
  2. Andrew Zelenetz (328)
  3. Ross Levine (312)
  4. Martin Tallman (298)
  5. Miguel-Angel Perales (292)
  6. Richard O'Reilly (281)

More People

Years
  1. 2025 (46)
  2. 2024 (430)
  3. 2023 (478)
  4. 2022 (369)
  5. 2021 (284)
  6. 2020 (261)

More Years

Publications
  1. Blood (5167)
  2. Blood Advances (322)
  3. Hematology-American Society of Hematology Education Program (50)

Results (5539)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A CD33-Deleted Allograft (Trem-cel) Enables Post-Hematopoietic Cell Transplant (HCT) Maintenance Dosing of Gemtuzumab Ozogamicin (GO) with Therapeutic Levels of Drug Exposure and Low Hematologic and Hepatic Toxicity in Patients with High-Risk Acute Myeloid Leukemia (AML)
    Meeting Abstract

    Dipersio, J. F.; Koehne, G.; Shah, N. N.; Bernard, L.; Suh, H. C.; Koura, D.; Perales, M. A.; Tamari, R.; Mushtaq, M. U.; Maakaron, J. E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Single-Cell Atlas of Diffuse Large B-Cell Lymphoma Reveals Integrated Malignant B Cell and Tumor Microenvironment Characteristics Associated with Clinical Response
    Meeting Abstract

    Baaklini, S.; Sarrabay, A.; Mazuel, A.; Escaliere, B.; Dong, C.; Barthelemy, C.; Gil, L.; Dahbi, L.; Mossadegh-Keller, N.; Van Acker, N.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Revumenib Monotherapy in Patients with Relapsed/Refractory KMT2Ar Acute Leukemia: Topline Efficacy and Safety Results from the Pivotal Augment-101 Phase 2 Study
    Meeting Abstract

    Aldoss, I.; Issa, G. C.; Thirman, M.; DiPersio, J.; Arellano, M.; Blachly, J. S.; Mannis, G. N.; Perl, A.; Dickens, D. S.; McMahon, C. M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Fixed-Duration Epcoritamab in Combination with Bendamustine plus Rituximab for First-Line Treatment of Follicular Lymphoma: Initial Results from Epcore NHL-2 Arm 3
    Meeting Abstract

    Brody, J.; Falchi, L.; Vitolo, U.; Nijland, M.; Offner, F.; Snauwaert, S.; Patah, P.; Marek, J.; Morehouse, C.; Steele, A. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Assessing Role of Comorbidities in Treatment Selection for Older Patients with Acute Myeloid Leukemia
    Meeting Abstract

    Grenet, J.; Easwar, N.; Jain, A. G.; Burkart, M.; Ma, X. Y.; Christos, P.; Ritchie, E. K.; Samuel, M.; Kaner, J. D.; Canaani, J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Development of the ASH Research Collaborative Multiple Myeloma Program: A Multicenter, Real-World Evidence Generation Network
    Meeting Abstract

    Kumar, S.; Wood, W. A.; Anderson, K. C.; Semmel, E. A.; James, S.; Neuberg, D. S.; Hewitt, K.; Schroeder, M. A.; Chung, D. J.; Rosenberg, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Transcriptomic and Epigenomic Landscape of Hairy Cell Leukemia at Single-Cell Resolution
    Meeting Abstract

    Eton, E. O.; Ganesan, S.; Murray, R. M.; Durham, B. H.; Park, J. H.; Abdel-Wahab, O.; Landau, D. A.
    Blood (2024)

    Fulltext@MSK | Save
  • Hematologic Improvement Experienced By Pacritinib-Treated Patients with Myelofibrosis in Real-World Clinical Settings
    Meeting Abstract

    Marrone, M.; Morere, L.; Oladapo, A.; Suthar, P.; Sura, T.; Vasudevan, A.; Vredenburg, M.; Zeng, J.; Rampal, R.; Mascarenhas, J. O.
    Blood (2024)

    Fulltext@MSK | Save
  • A Phase 1, Open-Label, Dose Escalation and Dose Expansion, Multicenter Clinical Trial to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of Lomonitinib (ZE46-0134) in Adults with FLT3-Mutated Relapsed or Refractory Acute Myeloid Leukemia
    Meeting Abstract

    Lin, T. L.; Koenig, K. L.; Swords, R. T.; Stein, E. M.; Baer, M. R.; Stock, W.; Madanat, Y. F.; Olin, R.; Blum, W.; Schiller, G. J.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • 24-hour urine testing does not add value to multiple myeloma response assessments: A secondary analysis of BMT CTN 0702
    Meeting Abstract

    Banerjee, R.; Fritz, A. R.; Akhtar, O. S.; Freeman, C. L.; Cowan, A. J.; Shah, N.; Landau, H. J.; Kumar, S.; Vogl, D. T.; Efebera, Y. A.; more...
    Blood (2024)

    Fulltext@MSK | Save